Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Presurgical models can effectively and affordably screen cancer prevention agents.

The document discusses a young boy with autism and early puberty but does not provide a conclusion on managing his behavior.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

BPH treatments are improving with personalized medicine and better surgical options.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

High TSPEAR levels in colorectal cancer predict worse outcomes.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Gene differences affect finasteride side effects in men with hair loss.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

An infant with Hutchinson-Gilford Progeria Syndrome had successful surgery to fix breathing issues caused by a new genetic mutation.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Obesity and certain hormone levels can lead to advanced bone age in young girls with early breast development.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Finasteride shows promise for preventing prostate cancer, but more research is needed.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.